logo

Clinical Trial Calendar

Share
Company Name Galmed Pharmaceuticals Ltd.
Event Name Topline data from phase 2b study of Aramchol (ARREST)
Indication Nonalcoholic steatohepatitis or NASH
Outcome Date
Outcome
Result Date Q2 2018
News
http://galmedpharma.investorroom.com/2017-11-09-Galmed-Pharmaceuticals-Reports-Third-Quarter-2017-Financial-Results-and-Provides-Business-Update
Return to Clinical Trial Calendar